Resistin Induces Hypertension and Insulin Resistance in Mice via a TLR4-Dependent Pathway

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Jiang, Yun ^a   Lu, Linfang ^a   Hu, Youtao ^c   Li, Qiang ^b   An, Chaoqiang ^a   Yu, Xiaolan ^a   Shu, Le ^a   Chen, Ao ^a   Niu, Congcong ^a   Zhou, Lei ^b   Yang, Zaiqing ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b GUANGXI UNIVERSITY   (China)

^c TONGREN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGT PROTEIN, MOUSE; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; RELA PROTEIN, MOUSE; RESISTIN; RETN PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

ANIMAL; BLOOD PRESSURE; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; GENETICS; HEP-G2 CELL LINE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TUMOR CELL LINE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINOGEN; ANIMALS; BLOOD PRESSURE; CELL LINE, TUMOR; HEP G2 CELLS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERINDOPRIL; RENIN-ANGIOTENSIN SYSTEM; RESISTIN; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 84959441423     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22193     Document Type: Article

References (32)

1. Lago, R. M., Singh, P. P. & Nesto, R. W. Diabetes and hypertension. Nature Clinical Practice Endocrinology & Metabolism. 3, 667-667 (2007).
2. Sowers, J. R., Epstein, M. & Frohlich, E. D. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 37, 1053-9 (2001).
3. DeFronzo, R. A. & Ferrannini, E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14, 173-94 (1991).
4. Groop, L. et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 36, 642-647 (1993).
5. Koerner, A., Kratzsch, J. & Kiess, W. Adipocytokines: leptin - the classical, resistin - the controversical, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab. 19, 525-46 (2005).
6. Muse, E. D. et al. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest. 114, 232-9 (2004).
7. Steppan, C. M. et al. The hormone resistin links obesity to diabetes. Nature. 409, 307-12 (2001).
8. Jamaluddin, M. S., Weakley, S. M., Yao, Q. & Chen, C. Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol. 165, 622-632 (2012).
9. Gentile, M. T. et al. Resistin impairs insulin-evoked vasodilation. Diabetes. 57, 577-83 (2008).
10. Calabro, P., Samudio, I., Willerson, J. T. & Yeh, E. T. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation. 110, 3335-3340 (2004).
11. Benomar, Y. et al. Central resistin overexposure induces insulin resistance through Toll-like receptor 4. Diabetes. 62, 102-114 (2013).
12. Tarkowski, A., Bjersing, J., Shestakov, A. & Bokarewa, M. I. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 14, 1419-31 (2010).
13. Zhou, L. et al. Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway. Hepatology. 57, 1384-93 (2013).
14. Deb, D. K. et al. 1, 25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-κ B pathway. American Journal of Physiology-Renal Physiology. 296, F1212-F1218 (2009).
15. Sowers, J. R. Insulin resistance and hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 286, H1597-H1602 (2004).
16. Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C. & Sharma, A. M. Resistin gene expression in human adipocytes is not related to insulin resistance. Obesity research. 10, 1-5 (2002).
17. Silha, J. V. et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. European Journal of Endocrinology. 149, 331-335 (2003).
18. Verma, S. et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 108, 736-40 (2003).
19. Shen, Y. H. et al. Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cells. Journal of Biological Chemistry. 281, 7727-7736 (2006).
20. Chen, C. et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. American Journal of Physiology-Heart and Circulatory Physiology. 299, H193-H201 (2010).
21. Herichova, I. & Szantoova, K. Renin-angiotensin system: upgrade of recent knowledge and perspectives. Endocr Regul. 47, 39-52 (2013).
22. Jeunemaitre, X. et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71, 169-80 (1992).
23. Bertolani, C. et al. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol. 169, 2042-53 (2006).
24. Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U. & Tarkowski, A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 174, 5789-95 (2005).
25. Lehrke, M. et al. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 1, e45 (2004).
26. Steppan, C. M. & Lazar, M. A. The current biology of resistin. J Intern Med. 255, 439-447 (2004).
27. Heilbronn, L. et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. Journal of Clinical Endocrinology & Metabolism. 89, 1844-1848 (2004).
28. Kusminski, C. M., McTernan, P. G. & Kumar, S. Role of resistin in obesity, insulin resistance and Type II diabetes. Clin Sci (Lond). 109, 243-56 (2005).
29. Fang, C. et al. Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension. Chinese medical journal. 126, 646-649 (2013).
30. Schwartz, D. R. & Lazar, M. A. Human resistin: found in translation from mouse to man. Trends in Endocrinology & Metabolism. 22, 259-265 (2011).
31. Chen, C. et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. American Journal of Physiology-Heart and Circulatory Physiology. 299, H193-H201 (2010).
32. Verma, S. et al. Resistin promotes endothelial cell activation further evidence of adipokine-endothelial interaction. Circulation. 108, 736-740 (2003).